{"mainPropery":{"diseaseId":10212,"diseaseName":"Congenital generalized lipodystrophy type 2","hasGardWebPage":false,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10212/congenital-generalized-lipodystrophy-type-2","synonyms":["Berardinelli Seip congenital lipodystrophy type 2","Berardinelli syndrome","Total lipodystrophy and acromegaloid gigantism","BSCL2-Related Brunzell syndrome"],"synonyms-with-source":[{"name":"Berardinelli Seip congenital lipodystrophy type 2"},{"name":"Berardinelli syndrome"},{"name":"Total lipodystrophy and acromegaloid gigantism"},{"name":"BSCL2-Related Brunzell syndrome","source":"OMIM"}],"identifiers":[{"identifierType":"OMIM","identifierId":"269700"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases"},{"diseaseTypeId":8,"diseaseTypeName":"Endocrine Diseases"},{"diseaseTypeId":22,"diseaseTypeName":"Skin Diseases"}],"organizations":[{"resourceID":138,"resourceName":"Metabolic Support UK","abbreviation":"","address1":"5 Hilliards Court","address2":"Sandpiper Way","address3":"Chester Business Park","address4":"","address5":"","city":"Chester","state":"","zip":"CH4 9QP","country":"United Kingdom","phone":"0845 241 2173","tty":"","tollFree":"0800 652 3181 ","fax":"","email":"https://www.metabolicsupportuk.org/contact-us","url":"https://www.metabolicsupportuk.org","freeText":""},{"resourceID":917,"resourceName":"American Dietetic Association","address1":"120 South Riverside Plaza, Suite 2000","address2":"","address3":"","address4":"","city":"Chicago","state":"IL","zip":"60606-6995","country":"United States","phone":"","tollFree":"800-366-1655","fax":"","email":"knowledge@eatright.org","url":"http://www.eatright.org/Public/"}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/269700' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?itool=omim_Detailed&DbFrom=omim&Cmd=Link&LinkName=omim_pubmed_calculated&IdsFromResult=269700' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Congenital generalized lipodystrophy type 2. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C1720863' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=bscl' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1756,"resourceId":2916,"resourceName":"NORD Physician Guide","descriptionText":"The <a href='https://rarediseases.org/physician-guide/lipodystrophy-disorders/' target='_blank'>NORD Physician Guide</a> for Congenital generalized lipodystrophy type 2 was developed as a free service of the National Organization for Rare Disorders (NORD) and it's medical advisors. &nbsp;The guides provide a resource for clinicians about specific rare disorders to facilitate diagnosis and treatment of their patients with this condition.&nbsp;","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:269700' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":0,"dateModified":"0001-01-01T00:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":13388,"relatedDiseaseName":"Congenital generalized lipodystrophy","relation":"Parent","isRare":true,"hasGardPage":true},{"relatedDiseaseId":12597,"relatedDiseaseName":"Genetic lipodystrophy","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":10285,"phenoTypeName":"Acanthosis nigricans","percentRanges":"-"},{"phenoTypeId":15063,"phenoTypeName":"Accelerated skeletal maturation","percentRanges":"-"},{"phenoTypeId":3876,"phenoTypeName":"Acute pancreatitis","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":5689,"phenoTypeName":"Cirrhosis","percentRanges":"-"},{"phenoTypeId":6198,"phenoTypeName":"Clitoral hypertrophy","percentRanges":"-"},{"phenoTypeId":6258,"phenoTypeName":"Congenital onset","percentRanges":"-"},{"phenoTypeId":7921,"phenoTypeName":"Cystic angiomatosis of bone","percentRanges":"-"},{"phenoTypeId":9739,"phenoTypeName":"Decreased fertility","percentRanges":"-"},{"phenoTypeId":6059,"phenoTypeName":"Decreased fertility in females","percentRanges":"-"},{"phenoTypeId":10978,"phenoTypeName":"Decreased serum leptin","percentRanges":"-"},{"phenoTypeId":4319,"phenoTypeName":"Elevated hepatic transaminase","percentRanges":"-"},{"phenoTypeId":5291,"phenoTypeName":"Generalized muscular appearance from birth","percentRanges":"-"},{"phenoTypeId":5695,"phenoTypeName":"Hepatic steatosis","percentRanges":"-"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","percentRanges":"-"},{"phenoTypeId":4769,"phenoTypeName":"High pitched voice","percentRanges":"-"},{"phenoTypeId":8284,"phenoTypeName":"Hirsutism","percentRanges":"-"},{"phenoTypeId":6044,"phenoTypeName":"Hyperinsulinemia","percentRanges":"-"},{"phenoTypeId":13752,"phenoTypeName":"Hypertriglyceridemia","percentRanges":"-"},{"phenoTypeId":8970,"phenoTypeName":"Hypertrophic cardiomyopathy","percentRanges":"-"},{"phenoTypeId":6069,"phenoTypeName":"Insulin-resistant diabetes mellitus at puberty","percentRanges":"-"},{"phenoTypeId":8722,"phenoTypeName":"Intellectual disability, mild","percentRanges":"-"},{"phenoTypeId":9995,"phenoTypeName":"Labial hypertrophy","percentRanges":"-"},{"phenoTypeId":3068,"phenoTypeName":"Large hands","percentRanges":"-"},{"phenoTypeId":4960,"phenoTypeName":"Lipodystrophy","percentRanges":"-"},{"phenoTypeId":5068,"phenoTypeName":"Long foot","percentRanges":"-"},{"phenoTypeId":11332,"phenoTypeName":"Macrotia","percentRanges":"-"},{"phenoTypeId":10381,"phenoTypeName":"Mandibular prognathia","percentRanges":"-"},{"phenoTypeId":14159,"phenoTypeName":"Nephrolithiasis","percentRanges":"-"},{"phenoTypeId":9740,"phenoTypeName":"Polycystic ovaries","percentRanges":"-"},{"phenoTypeId":13767,"phenoTypeName":"Polyphagia","percentRanges":"-"},{"phenoTypeId":4726,"phenoTypeName":"Prominent umbilicus","percentRanges":"-"},{"phenoTypeId":5360,"phenoTypeName":"Reduced intraabdominal adipose tissue","percentRanges":"-"},{"phenoTypeId":7376,"phenoTypeName":"Reduced intrathoracic adipose tissue","percentRanges":"-"},{"phenoTypeId":5320,"phenoTypeName":"Reduced subcutaneous adipose tissue","percentRanges":"-"},{"phenoTypeId":3886,"phenoTypeName":"Splenomegaly","percentRanges":"-"},{"phenoTypeId":10035,"phenoTypeName":"Tall stature","percentRanges":"-"},{"phenoTypeId":10399,"phenoTypeName":"Triangular face","percentRanges":"-"},{"phenoTypeId":4092,"phenoTypeName":"Umbilical hernia","percentRanges":"-"},{"phenoTypeId":13472,"phenoTypeName":"Ventricular septal hypertrophy","percentRanges":"-"}],"medicalProducts":[{"productId":589,"genericName":"metreleptin","tradeName":"Myalept","tradeLink":"http://www.astrazeneca.com/Media/Press-releases/Article/20140225--us-fda-approves-orphan-drug-myalept","manufacturer":"","sponsor":"Amylin Pharmaceuticals, LLC","indication":"Adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy.  ","drugInformationLink":"http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=MYALEPT","medlinePlusLink":""}],"EncodedName":"Congenital_generalized_lipodystrophy_type_2"}